Systemic lupus erythematosus (SLE) is the prototypic multisystem autoimmune disorder with a broad spectrum of clinical presentations encompassing almost all organs and tissues. Aimes of study determination of integrin- linked kinase 1(ILK-1) and anti-smith antibody(ASAB) levels in serum of Iraqi patients with systemic lupus erythematosus, in addition, that ILK-1 may be as a diagnostic marker of SLE disease, and study the effect of systemic lupus erythematosus on renal function in these patients. This study included 100 females’ patients with systemic lupus erythematosus attending to the Rheumatology Unit in Baghdad Teaching Hospital, Medical City, (Baghdad), in addition to 30 healthy females as controller group were chosen without any chronic diseases. All study individuals with ages ranged from (18-48) years. All patients were classifying according to the severity by the SLE disease activity index (SLEDAI) by using Rheuma Helper into 30 female patients with mild stage as (G1), 40 female patients with moderate stage as (G2), and 30 female patients with severe stage as (G3). Results in the current study display a significant elevation in dsDNA, ANA, ASAB, ILK-1, urea, and uric acid levels in G1, G2, and G3 patients’ groups compared with control (C) group. Creatinine levels showed no difference in its levels in G1,G2, and G3 comparing to control group. The current results showed that there were various significant comparisons between ILK-1 and other study parameters in the control and patient groups. ROC test for ILK-1 and ASAB markers showed a perfect cut off value with 100% sensitivity and 100% specificity. Conclusions TK-1 may be helpful as a novel biomarker in the diagnosis of SLE disease, and there was a positive correlation between ILK-1 with urea and creatinine that are considered factors of renal damage. this is evidence that there is an effect of SLE disease on kidney function, and thus these patients may be at risk for kidney dysfunction at severe stage